Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Jan 24, 2021; 12(1): 31-42
Published online Jan 24, 2021. doi: 10.5306/wjco.v12.i1.31
Published online Jan 24, 2021. doi: 10.5306/wjco.v12.i1.31
Adaptation of international coronavirus disease 2019 and breast cancer guidelines to local context
Guillermo Arturo Valencia, Silvia Neciosup, Henry L Gómez, Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas (INEN), Surquillo 15000, Lima, Peru
Silvia Neciosup, Henry L Gómez, Clínica Oncosalud – AUNA, Surquillo 15000, Lima, Peru
Maria Del Pilar Benites, Breast Cancer Unit, Hospital Nacional Edgardo Rebagliati Martins, Lima 15000, Peru
Silvia Falcón, Department of Medical Oncology, Centro Oncológico Aliada, Lima 15000, Peru
David Moron, Department of Medical Oncology, Hospital Nacional Carlos Alberto Seguín Escobedo, Arequipa 04001, Peru
Karin Veliz, Department of Medical Oncology, Hospital Nacional Ramiro Prialé Prialé, Huancayo 12000, Peru
Mike Maldonado, Department of Medical Oncology, Instituto Regional de Enfermedades Neoplásicas (IREN), Trujillo 13001, Peru
Rodrigo Auqui, Department of Medical Oncology, Hospital Nacional Almanzor Aguinaga Asenjo, Chiclayo 14001, Peru
Author contributions: Valencia GA wrote the paper and collected data; All the authors discussed the review article and made a consensus by vote.
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Guillermo Arturo Valencia, MD, Medical Assistant, Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas (INEN), Angamos Este Avenue 2520, Surquillo 15000, Lima, Peru. guillermo.valencia.mesias@gmail.com
Received: September 4, 2020
Peer-review started: September 4, 2020
First decision: November 16, 2020
Revised: November 23, 2020
Accepted: December 4, 2020
Article in press: December 4, 2020
Published online: January 24, 2021
Processing time: 135 Days and 7.8 Hours
Peer-review started: September 4, 2020
First decision: November 16, 2020
Revised: November 23, 2020
Accepted: December 4, 2020
Article in press: December 4, 2020
Published online: January 24, 2021
Processing time: 135 Days and 7.8 Hours
Core Tip
Core Tip: This manuscript includes some recommendations about oncological medical treatment of breast cancer in coronavirus disease 2019 pandemic that were selected from three international clinical practice guidelines. These were reviewed and adapted to local context by a panel of experts from Peru invited by the Peruvian Society of Medical Oncology using levels of prioritization. Consensus was made, including a vote, in order to provide best decisions of management, avoid duplication of efforts and optimize medical resources, considering health care system reality. These recommendations are not intended to replace clinical judgment.